0001144204-11-030002.txt : 20110516 0001144204-11-030002.hdr.sgml : 20110516 20110516161033 ACCESSION NUMBER: 0001144204-11-030002 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110516 DATE AS OF CHANGE: 20110516 EFFECTIVENESS DATE: 20110516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 IRS NUMBER: 830406777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12884 FILM NUMBER: 11846924 BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 v222838_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2011 Check here if Amendment [_]; Amendment Number: ___________ This Amendment (Check only one): [_] is a restatement. [_] adds new entries. Institutional Investment Manager Filing this Report: Name: RA Capital Management, LLC ------------------------------------- Address: 20 Park Plaza, Suite 905 ------------------------------------- Boston, MA 02116 ------------------------------------- Form 13F File Number: 28-12884 -------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter Kolchinsky ------------------------------------- Title: Manager ------------------------------------- Phone: (617) 778-2500 ------------------------------------- Signature, Place, and Date of Signing /s/ Peter Kolchinsky Boston, MA May 16, 2011 -------------------------- -------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------------- Form 13F Information Tabel Entry Total: 27 ----------------- Form 13F Information Table Value Total: 151,197 ----------------- (thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 --------------------------- ------------ ----------- -------- ---------------------- ---------- -------- --------------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE/ SHARED/NONE ------------------------------------------------------------------------------------------------------------------------------------ ACADIA PHARMACEUTICALS INC COM 004225 10 8 8,381 5,173,708 SH SOLE N/A 5,173,708 ADVENTRX PHARMACEUTICALS INC COM NEW 00764X 20 2 4,967 2,365,000 SH SOLE N/A 2,365,000 AFFYMAX INC COM 00826A 10 9 9,814 1,671,908 SH SOLE N/A 1,671,908 ALEXION PHARMACEUTICALS INC COM 015351 10 9 9,972 101,050 SH SOLE N/A 101,050 ARQULE INC COM 04269E 10 7 814 114,074 SH SOLE N/A 114,074 ARTHROCARE CORP COM 043136 10 0 9,679 290,319 SH SOLE N/A 290,319 BIOSPECIFICS TECHNOLOGIES CO COM 090931 10 6 5,976 234,362 SH SOLE N/A 234,362 COLUMBIA LABS INC COM 197779 10 1 4,057 1,076,116 SH SOLE N/A 1,076,116 DERMA SCIENCES INC COM PAR $.01 249827 50 2 436 44,940 SH SOLE N/A 44,940 DISCOVERY LABORATORIES INC N COM NEW 254668 40 3 1,064 575,000 SH SOLE N/A 575,000 DYNAVAX TECHNOLOGIES CORP COM 268158 10 2 6,047 2,191,071 SH SOLE N/A 2,191,071 ENDOCYTE INC COM 29269A 10 2 2,049 239,100 SH SOLE N/A 239,100 ENZO BIOCHEM INC COM 294100 10 2 787 187,900 SH SOLE N/A 187,900 GILEAD SCIENCES INC COM 375558 10 3 8,069 190,000 SH SOLE N/A 190,000 INHIBITEX INC COM 45719T 10 3 1,090 301,200 SH SOLE N/A 301,200 JAZZ PHARMACEUTICALS INC COM 472147 10 7 6,861 215,424 SH SOLE N/A 215,424 MAXYGEN INC COM 577776 10 7 926 178,015 SH SOLE N/A 178,015 ONCOGENEX PHARMACEUTICALS IN COM 68230A 10 6 8,082 528,255 SH SOLE N/A 528,255 ONCOTHYREON INC COM 682324 10 8 916 236,739 SH SOLE N/A 236,739 OPKO HEALTH INC COM 68375N 10 3 560 150,000 SH SOLE N/A 150,000 PHARMASSET INC COM 71715N 10 6 11,630 147,761 SH SOLE N/A 147,761 REPLIGEN CORP COM 759916 10 9 3,328 889,741 SH SOLE N/A 889,741 SEQUENOM INC COM NEW 817337 40 5 15,615 2,462,879 SH SOLE N/A 2,462,879 TARGACEPT INC COM 87611R 30 6 10,714 402,938 SH SOLE N/A 402,938 TENGION INC COM 88034G 10 9 2,640 1,060,070 SH SOLE N/A 1,060,070 UNITED THERAPEUTICS CORP DEL COM 91307C 10 2 6,906 103,050 SH SOLE N/A 211,500 VALEANT PHARMACEUTICALS INTL COM 91911K 10 2 10,535 211,500 SH SOLE N/A 211,500